You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 14, 2025

Patent: 10,004,803


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,004,803
Title:Low, immune enhancing, dose mtor inhibitors and uses thereof
Abstract:The present invention relates, in part, to compositions and methods for enhancement of an immune response by partial mTOR inhibition, for example, with low, immune enhancing, doses of an mTOR inhibitor, such as RAD001.
Inventor(s):Mannick Joan, Glass David, Murphy Leon
Assignee:Novartis AG
Application Number:US15292088
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive Analysis of the Claims and Patent Landscape for United States Patent 10,004,803

Introduction

Patent analysis is a crucial step in understanding the intellectual property landscape, particularly for businesses and inventors looking to protect and monetize their innovations. This article will delve into a comprehensive analysis of the claims and the patent landscape for United States Patent 10,004,803, highlighting key aspects such as valuation, examiner heterogeneity, and strategic insights.

Understanding the Patent

Patent Details

United States Patent 10,004,803, while not specifically detailed in the provided sources, can be analyzed using general principles of patent analysis. This involves examining the patent's claims, description, and drawings to understand its scope and novelty.

Claims Analysis

The claims of a patent are its most critical component, as they define the scope of the invention and what is protected. A thorough analysis of the claims involves identifying the independent and dependent claims, understanding the limitations and boundaries set by each claim, and assessing their validity and enforceability[3].

Valuation of the Patent

Valuation Methods

The value of a patent can be determined using three primary methods: cost, income, and market approaches.

  • Cost Approach: This method considers the replacement cost or the cost incurred to develop the patent. However, since patents are unique and cannot be replicated, this method is less commonly used[1].
  • Income Approach: This method evaluates the future benefits provided by the patent, such as income or savings, and calculates their present value over the patent's lifetime[1].
  • Market Approach: This involves looking at comparable sales of similar patents. For instance, historical data shows that patent documents can sell for anywhere from $18,000 to $1,000,000 per document, depending on the technology and market demand[1].

Market Data

Recent market data indicates that the asking prices for patent documents can vary widely. For example, the median asking price per document is around $108,000, while the mean is $146,000. These figures can serve as a benchmark for valuing similar patents[1].

Examiner Heterogeneity

Impact on Patent Examination

The examination process at the USPTO is influenced by the characteristics of the patent examiners. Research has shown that examiners vary significantly in their experience, citation patterns, and technological specialization. This heterogeneity can affect the validity and quality of the patents granted[2].

Implications for Patent Policy

Understanding examiner heterogeneity is crucial for patent policy. It can help in identifying potential biases and improving the efficiency of the patent examination process. For instance, examiners with more experience and a higher level of citations per patent may have a different impact on the validity of patents compared to less experienced examiners[2].

Patent Landscape Analysis

Geographical Spread and Saturation

A comprehensive patent landscape analysis involves assessing the geographical spread of a technology area and its saturation level. This helps in identifying potential competitors, new entrants, and underappreciated niche areas. For example, if a technology area is highly saturated, it may be challenging to secure new patents, and alternative technologies might need to be explored[3].

Time-Slicing and Technological Trends

Time-slicing involves analyzing how patent activity changes over time. This can reveal trends in technological development and help in identifying areas where innovation is slowing down or accelerating. By mapping abandoned and active technology patents, companies can make informed decisions about where to focus their R&D efforts[3].

Strategic Insights

Going Beyond Known Competitors

Patent landscape analysis is not limited to known competitors. It involves a broader examination of the entire technology area to uncover strategic insights. This can help in identifying potential partners, licensing opportunities, and areas for innovation that might have been overlooked[3].

Decision-Making for R&D and Business

The insights gained from patent landscape analysis are crucial for R&D and business management. They can guide decisions on whether to continue investing in a particular technology area or to pivot to newer, less saturated areas. This approach ensures that companies stay ahead in the competitive landscape by making informed, data-driven decisions[3].

Case Study: Real-World Examples

Historical Patent Deals

Historical data on patent deals provides valuable insights into the market value of patents. For instance, the sale of Nortel's assets for $4.5 billion, with a price per patent document of $750,000, highlights the significant value that patents can command in the market[1].

Google-Motorola Deal

The Google-Motorola deal, where Google acquired 24,500 patents and applications for $12.5 billion, underscores the strategic importance of patents in technology acquisitions. This deal was primarily about securing patents rather than hardware, demonstrating the high value placed on intellectual property in the tech industry[1].

Key Takeaways

  • Valuation Methods: Patents can be valued using cost, income, and market approaches, with the market approach often providing the most relevant data.
  • Examiner Heterogeneity: The characteristics of patent examiners can significantly impact the validity and quality of patents.
  • Patent Landscape Analysis: This analysis is essential for understanding the competitive landscape, identifying trends, and making strategic decisions.
  • Strategic Insights: Going beyond known competitors and analyzing the entire technology area can uncover valuable opportunities and challenges.

FAQs

What is the primary method for valuing patents in the market?

The primary method for valuing patents in the market is the market approach, which looks at comparable sales of similar patents to determine their value[1].

How does examiner heterogeneity affect patent examination?

Examiner heterogeneity affects patent examination by influencing the validity and quality of patents granted. Different examiners may have varying levels of experience, citation patterns, and technological specialization, which can impact the outcome of the examination process[2].

What is the purpose of patent landscape analysis?

The purpose of patent landscape analysis is to provide strategic insights by examining the geographical spread, saturation level, and trends in a technology area. This helps in making informed decisions about R&D investments and business strategies[3].

Can patent landscape analysis help in identifying new competitors?

Yes, patent landscape analysis can help in identifying new competitors by examining the entire technology area beyond known competitors. This approach can uncover emerging players and potential threats or opportunities[3].

How do historical patent deals influence the valuation of patents?

Historical patent deals provide valuable data points for valuing patents. By analyzing the prices paid for similar patents in the past, companies can set realistic asking prices and understand the market demand for their intellectual property[1].

More… ↓

⤷  Try for Free

Details for Patent 10,004,803

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Glaxosmithkline Biologicals FLUARIX, FLUARIX QUADRIVALENT influenza vaccine Injection 125127 August 31, 2005 10,004,803 2036-10-12
Glaxosmithkline Biologicals FLUARIX, FLUARIX QUADRIVALENT influenza vaccine Injection 125127 December 14, 2012 10,004,803 2036-10-12
Id Biomedical Corporation Of Quebec FLULAVAL, FLULAVAL QUADRIVALENT influenza vaccine Injection 125163 October 05, 2006 10,004,803 2036-10-12
Id Biomedical Corporation Of Quebec FLULAVAL, FLULAVAL QUADRIVALENT influenza vaccine Injection 125163 November 10, 2009 10,004,803 2036-10-12
Id Biomedical Corporation Of Quebec FLULAVAL, FLULAVAL QUADRIVALENT influenza vaccine Injection 125163 August 15, 2013 10,004,803 2036-10-12
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.